蛋白尿
肾病综合征
医学
膜性肾病
自发缓解
内科学
胃肠病学
入射(几何)
肾
病理
光学
物理
替代医学
作者
Natalia Polanco,Elena Gutiérrez,A Covarsí,Francisco Ariza,Agustín Carreño,Ana Vigil,José Baltar,Gema Fernández‐Fresnedo,Carmen Martín,Salvador Pons,D. Lorenzo,Carmen Bernis,Pilar Arrizabalaga,Gema Fernández‐Juárez,V. Barrio,Milagros Sierra,Ines Castellanos,Mario Espinosa,Francisco Rivera,Aniana Oliet
出处
期刊:Journal of The American Society of Nephrology
日期:2010-01-29
卷期号:21 (4): 697-704
被引量:346
标识
DOI:10.1681/asn.2009080861
摘要
Spontaneous remission is a well known characteristic of idiopathic membranous nephropathy, but contemporary studies describing predictors of remission and long-term outcomes are lacking. We conducted a retrospective, multicenter cohort study of 328 patients with nephrotic syndrome resulting from idiopathic membranous nephropathy that initially received conservative therapy. Spontaneous remission occurred in 104 (32%) patients: proteinuria progressively declined after diagnosis until remission of disease at 14.7 +/- 11.4 months. Although spontaneous remission was more frequent with lower levels of baseline proteinuria, it also frequently occurred in patients with massive proteinuria: 26% among those with baseline proteinuria 8 to 12 g/24 h and 22% among those with proteinuria >12 g/24 h. Baseline serum creatinine and proteinuria, treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, and a >50% decline of proteinuria from baseline during the first year of follow-up were significant independent predictors for spontaneous remission. Only six patients (5.7%) experienced a relapse of nephrotic syndrome. The incidence of death and ESRD were significantly lower among patients with spontaneous remission. In conclusion, spontaneous remission is common among patients with nephrotic syndrome resulting from membranous nephropathy and carries a favorable long-term outcome with a low incidence of relapse. A decrease in proteinuria >50% from baseline during the first year predicts spontaneous remission.
科研通智能强力驱动
Strongly Powered by AbleSci AI